Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 1.00 |
| ▸ | CCR5 | P51681 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7555954 | 0.83 | CCR1 (0.69) | CCR1CCR5PARP1PDE10AKDM4E | |
| SCHEMBL9220073 | 0.80 | CCR1 (0.65) | CCR1RAB9APDE10AKDM4ELMNA | |
| SCHEMBL14478402 | 0.79 | CCR1 (0.63) | CCR1RAB9AKDM4ELMNAHTT | |
| SCHEMBL7806536 | 0.79 | CCR1 (0.63) | CCR1RAB9APARP1PDE10ANOTUM | |
| SCHEMBL8588461 | 0.79 | CCR1 (0.63) | CCR1PARP1PDE10AKDM4ECYP3A4 | |
| SCHEMBL1498632 | 0.75 | CCR1 (0.59) | CCR1CCR5PARP1KDM4ELMNA | |
| SCHEMBL3277356 | 0.74 | PDE10A (0.61) | CCR1PDE10A | |
| SCHEMBL17436930 | 0.73 | CCR1 (0.55) | CCR1 | |
| SCHEMBL15581732 | 0.72 | CCR1 (0.56) | CCR1CCR5RAB9APARP1PDE10A | |
| SCHEMBL31648790 | 0.72 | CCR1 (0.56) | CCR1CCR5RAB9APARP1PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103242827-B | Florescent ion probe reagent for zinc ion detection and preparation method thereof | UNIV NANKAI | 2014-08-06 | — | — | CN | claimed |
| US-7238832-B2 | Production method of a coupling compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-03 | — | — | US | claimed |
| EP-1449580-B1 | Production method of a cross-coupling compound from an alkyl halide and an organoboron compound | SUMITOMO CHEMICAL CO (JP) | 2005-12-28 | — | — | EP | claimed |
| US-20040167364-A1 | Production method of a coupling compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-08-26 | — | — | US | claimed |
| EP-1449580-A1 | Production method of a cross-coupling compound from an alkyl halide and an organoboron compound | Sumitomo Chemical Co.,Ltd. (JP) | 2004-08-25 | — | — | EP | claimed |
| CN-119118821-A | Rare earth carboxylic acid complex, preparation method and application thereof | 包头稀土研究院 | 2024-12-13 | — | — | CN | disclosed |
| CN-113201335-B | Enhanced fluorescent carbon dot, preparation method and application in cadmium ion detection | 江南大学 | 2022-07-05 | — | — | CN | disclosed |
| CN-113201335-A | Enhanced fluorescent carbon dot, preparation method and application in cadmium ion detection | 江南大学 | 2021-08-03 | — | — | CN | disclosed |
| WO-2019243546-A1 | COATING COMPOSITION | PPG EUROPE B.V. (NL) | 2019-12-26 | — | — | WO | disclosed |
| CN-103242827-B | Florescent ion probe reagent for zinc ion detection and preparation method thereof | UNIV NANKAI | 2014-08-06 | — | — | CN | disclosed |
| CN-103242827-B | Florescent ion probe reagent for zinc ion detection and preparation method thereof | UNIV NANKAI | 2014-08-06 | — | — | CN | disclosed |
| CN-103242827-A | Florescent ion probe reagent for zinc ion detection and preparation method thereof | UNIV NANKAI | 2013-08-14 | — | — | CN | disclosed |
| EP-1242824-A2 | SCREENING USING BIOLOGICAL TARGET MOLECULES WITH METAL-ION BINDING SITES | 7TM Pharma (DK) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001050127-A9 | SCREENING USING BIOLOGICAL TARGET MOLECULES WITH METAL-ION BINDING SITES | 7TM PHARMA (DK) | 2002-09-12 | — | — | WO | disclosed |
| US-20020061599-A1 | Method of identifying ligands of biological target molecules | 7TM PHARMA (DK) | 2002-05-23 | — | — | US | disclosed |
| WO-2001050127-A2 | SCREENING USING BIOLOGICAL TARGET MOLECULES WITH METAL-ION BINDING SITES | 7TM PHARMA (DK) | 2001-07-12 | — | — | WO | disclosed |
| US-5637311-A | ANTIVIRAL AGENTS AND/OR ANTIINFLAMMATORY AGENTS | PROCYTE CORPORATION (US) | 1997-06-10 | — | — | US | disclosed |
| US-4859777-A | Terpyridine chelating agents | EASTMAN KODAK COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| US-4837169-A | RADIOIMMUNOASSAY | EASTMAN KODAK COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| EP-0288256-A2 | Fluorescent labels | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167364-A1 | Production method of a coupling compound | PYM1, BRIX1, CXCR1 | CCR1 94/4885CCR5 973/4885RAB9A 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.